The distribution of disease-associated prion protein (PrP) was investigated in eight animals (20-24 months of age) from a flock of Suffolk sheep that had experienced frequent cases of natural scrapie over a period of several years. Tissue from the central nervous system (CNS), alimentary tract, peripheral nervous system and lymphoreticular system was examined by histopathology and immunohistochemistry. The lymphoid tissues were subjected further to histoblot and immunofluorescence examination. 
Introduction
The accumulation of an abnormally folded, partially proteinase-resistant form of the prion protein (PrP) in nervous and lymphoid tissues occurs during the pathogenesis of scrapie, which is a transmissible spongiform encephalopathy (TSE) causing a fatal neurodegenerative disorder in sheep and goats. The localization of the abnormal isoform of PrP in lymphoid nodules of secondary lymphoid tissues, such as lymph nodes and spleen, is a distinctive feature of lymphoreticular involvement in scrapie (van Keulen et al., 1996) . Given the close relationship between the TSE agent and the abnormal isoform Author for correspondence : Charles Press.
Fax j47 22 96 47 64. e-mail Charles. Press!veths.no of PrP in scrapie and other prion diseases (Bolton et al., 1982 ; Prusiner, 1982) , this PrP is often described as diseaseassociated PrP Jeffrey et al., 2000) .
The early accumulation of disease-associated PrP in lymphoid tissues has been shown to facilitate neuroinvasion (Lasme! zas et al., 1996) , although it has also been shown that neuroinvasion can occur without the involvement of lymphoid tissues (Kimberlin et al., 1983 ; Baldauf et al., 1997) . In scrapie, clinical disease is restricted to certain susceptible PrP genotypes within the various breeds of sheep (Westaway et al., 1994 ; Hunter, 1997 ; Hunter et al., 1997a) . However, some susceptible PrP genotypes of sheep, such as PrP VRQ \PrP ARR Texel sheep, do not show this characteristic distribution of diseaseassociated PrP in lymphoid nodules and the disease appears to occur in these sheep without lymphoreticular involvement (van Keulen et al., 2000) . Thus, the role of the lymphoreticular involvement in scrapie remains unclear.
Scrapie affects adult sheep of any age but the modal age of occurrence of clinical signs is 42 months and clinical cases are rare in sheep under 1 year of age (Bradley, 1997) . The accumulation of disease-associated PrP in lymphoid tissues precedes the appearance of clinical signs by many months and has been detected in sheep as young as 5 months of age exposed to natural scrapie (van Keulen et al., 2000) . Heggebø et al. (2000) recently reported changes in the distribution of PrP in gut-associated lymphoid tissues of lambs as early as 1 week after experimental oral exposure to scrapie-infected material. Furthermore, Andre! oletti et al. (2000) showed that the distribution of disease-associated PrP in lymphoid tissues increases as the disease progresses and suggested that infection of lymphoid tissues, particularly gut-associated lymphoid tissues, may lead to shedding of scrapie infectivity to the environment and thus indirectly contribute to the horizontal transmission of scrapie observed under natural field conditions. The closer definition of the involvement of lymphoreticular tissue in the pathogenesis of scrapie is relevant to both the early detection of infected animals and the elimination of possible sources of disease transmission.
Follicular dendritic cells (FDCs) have been implicated as the cells of the lymphoreticular system that sustain replication of the agent in TSEs (Brown et al., 1999 ; Kitamoto et al., 1991 ; McBride et al., 1992) . High levels of PrP are detected on FDCs in both TSE-infected and uninfected mice (Ritchie et al., 2000) and, although the presence of mature B cells has been shown to influence the course of infection in mice (Frigg et al., 1999 ; Klein et al., 1997) , most studies in mice demonstrate that FDCs are the dominant cell type harbouring PrP in the lymphoreticular system (Brown et al., 1999 ; Mabbott et al., 2000 ; Montrasio et al., 2000) . However, FDCs are a sessile cell population localized to the primary and secondary nodules of lymphoid tissues. Moreover, germinal centres of secondary nodules are poorly innervated (Felten et al., 1985) . Thus, while the accumulation and replication of disease-associated PrP in germinal centres may be specific for TSEs, these accumulations may also be a ' dead-end ' for the pathogenesis of the disease. Other cell types or processes must be involved in the lymphoreticular phase of TSEs, not only to bring the TSE agent into contact with germinal centre FDCs but also to transport the replicated agent to other sites in the host and eventually to shed the agent to the environment. Recent studies have suggested the involvement of mobile dendritic cells , while other investigators have implicated macrophages in the pathogenesis of TSEs (Andre! oletti et al., 2000 ; Beringue et al., 2000) . The distribution of diseaseassociated PrP in the lymphoid tissues of sheep approaching or within the early stages of clinical disease would be expected to provide an insight into the processes and cell populations involved in the lymphoreticular phase of scrapie. Accordingly, the present study was undertaken to investigate the distribution of PrP in the lymphoid tissues of Suffolk sheep in the late sub-clinical and early clinical phase of natural scrapie. Immunohistochemical detection of disease-associated PrP was compared with the distribution of proteinase-resistant PrP (PrP RES ) in histoblots and the co-localization of PrP and FDCs was evaluated in a sensitive immunofluorescence procedure.
Methods
Sheep and tissue collection. The pathology, epidemiology and genetics of scrapie infection in this flock have been described previously (Hunter et al., 1997b ; Jeffrey et al., 2000) . As described in other flocks of Suffolk sheep (O'Rourke et al., 1997 ; Westaway et al., 1994) , clinical disease occurs in PrP ARQ/ARQ homozygotes. Prior to 1997, cases of scrapie in this flock had been confirmed on the basis of histopathological changes in brain tissue.
In the present study, eight sheep were studied (Table 1) . Two PrP ARQ/ARQ , one PrP ARR/ARQ and one PrP ARR/ARR sheep were killed at 20 months of age. None of these sheep had any clinical evidence of disease. A further four sheep were killed at 23-24 months of age having had a short period with clinical signs consistent with scrapie.
From each sheep, tissue samples were collected for histological, immunohistochemical and histoblot analysis from the brain, spinal cord, lymphoid tissues and alimentary tract. The following lymphoid tissues were collected into 10 % buffered formalin : retropharyngeal, submandibular, superficial cervical, mesenteric and mediastinal lymph nodes ; tonsil, spleen and thymus and the third eyelid containing conjunctival lymphoid aggregates were collected from some sheep. From the alimentary tract, the following sites were identified and tissue samples were fixed in 10 % neutral buffered formalin or frozen in isopentane chilled in liquid nitrogen and stored at k70 mC until use : rumen (two sites), omasal-reticulum junction, abomasums (pylorus, greater and lesser curvature), duodenum, jejunum (several sites containing grossly identified Peyer's patches), ileal Peyer's patch near the insertion of the ileo-caecal fold and colon (adjacent to the ileo-caeco-colic junction and at the descending colon near to the spiral colon).
Immunohistochemistry in paraffin-embedded tissues. Avidin-biotin complex and peroxidase-anti-peroxidase immunohistochemical staining for disease-associated accumulations of PrP was conducted using modifications of methods published previously (Haritani et al., 1994) . Tissues were subjected to formic acid pre-treatment and hydrated autoclaving. Immunohistochemistry for the detection of PrP was performed using the R521.7 antibody, which was kindly provided by Jan Langeveld (IDLO, Lelystad, The Netherlands) (van Keulen et al., 1996) and several other monoclonal and polyclonal anti-PrP sera, including P4 and L42 (Hardt et al., 2000) , R145, R476, R482 and R486 (kindly provided by R. Jackman ; VLA Weybridge, Surrey, UK), 505, 532 and 523.7\524 (van Keulen et al., 1996) , 1A8 (Langeveld et al., 1993) , 1B3 (Farquhar et al., 1989 ; Garssen et al., 2000) , R24 (Caughey et al., 1991) and 1B4, BG4 and FH11 (unpublished) . The control sections included the use of either pre-bleed antiserum (1A8 and 1B3) or anti-isotype control sera as the primary antibody.
Histoblot. For histoblots, frozen sections (9 µm in thickness) were mounted on nitrocellulose (0n45 µm pore size ; Sigma) and treated in a standard manner (Taraboulos et al., 1992) , with some minor modifications.
Briefly, the tissues were subjected to proteolysis with 400 µg\ml proteinase K (Serva Electrophoresis) at 55 mC for 4 h. After rinsing in TBS, the membrane was incubated for 20 min with 3 mM PMSF followed by denaturation for 10 min in 3 M guanidine SCN (Sigma). To block nonspecific binding, 5 % non-fat milk was added to the membrane for 1 h. The membrane was then incubated with the anti-PrP monoclonal antibody L42 overnight at 4 mC. After rinsing in TBS, the membrane was incubated with a secondary anti-mouse antibody (Vectastain ABC kit ; Vector Laboratories) for 30 min, followed by incubation with streptavidinalkaline phosphatase conjugate (Amersham Pharmacia) for 30 min. A reaction product was produced using BCIP\NBT Pre-mixed Solution (Zymed) for 10 min. The histoblots were examined and images captured using a Leica DC100 digital camera mounted on a Leica MZ 12.5 Stereomicroscope.
EIA
Immunofluorescence in frozen tissues. Sections from frozen tissues were cut 7 µm in thickness and fixed in 10 % formol-calcium for 20 min. An indirect double immunofluorescence technique was used to detect the co-localization of an anti-PrP antibody (L42 ; isotype IgG " ) and an anti-CD21 antibody (Du2-74-25 ; isotype IgG #b ). A Coumarine kit (NEN Life Science Products) was used to enhance the detection of PrP. Previous studies have shown that enhancement procedures increase the sensitivity of PrP detection in frozen sections from lymphoid tissues in sheep (Heggebø et al., 2000) . Following fixation, the blocking reagent from the Coumarine kit was added to the sections for 15 min. The two primary antibodies were added simultaneously to the sections and the sections were incubated overnight at 4 mC. Coumarine-and FITC-labelled isotype-specific secondary antibodies were used to detect the anti-PrP and anti-CD21 antibodies, respectively. The sections were coverslipped with polyvinyl alcohol and examined with a Leica DMRXA microscope equipped for fluorescence (Leica Microsystems). Dark field fluorescence digital images were collected with a SPOT RT Slider digital camera (Diagnostic Instruments) using FITC and Coumarine filters. The control sections included the omission of one or both primary antibodies and\or one or both secondary antibodies. These control sections showed that non-specific staining was present in the crypt epithelium and lamina propria of the alimentary tissue sections and in connective tissue trabeculae in lymph nodes and spleen tissue sections.
Results

Histopathology and immunohistochemistry
Central nervous system (CNS). The results of histopathological and immunohistochemical examination of the CNS of the eight sheep in the present study are shown in Table 1 . The four PrP ARQ/ARQ animals with clinical signs that were consistent with scrapie showed vacuolation and disease-associated PrP accumulation in the CNS (data not shown). In the two PrP ARQ/ARQ sheep that did not show clinical signs, only limited vacuolation and PrP accumulation were detected in the brain. Moderate or sparse vacuolation was present in the dorsal vagal nucleus of both sheep. In one of these sheep, there was widespread accumulation of PrP in the brainstem and in the thoracic spinal cord. In the other sheep, disease-associated PrP was confined to the dorsal vagal nucleus in the brainstem and to the intermediolateral columns of the thoracic spinal cord. Accordingly, the two PrP ARQ/ARQ sheep that did not show clinical signs were assumed to be in the late sub-clinical phase of the disease (Table 1) . No histopathological evidence of vacuolation was present in the tissue sections from the brain of the PrP ARR/ARR or PrP ARR/ARQ sheep and brain tissue from these two animals contained no disease-associated accumulations of PrP.
Lymphoid tissue. Histopathological lesions were not detected in any of the lymphoid tissues examined. As described previously for lymphoid tissues from clinical scrapie in Swifter and Texel sheep (van Keulen et al., 1996) , the clinical cases of scrapie in PrP ARQ/ARQ Suffolk sheep showed generalized PrP accumulation in most germinal centres of all lymph nodes examined (Table 1) . PrP accumulations were also present in the two animals assumed to be in the late sub-clinical phase of scrapie. In the immunohistochemical examination of lymphoid tissues, disease-associated accumulations of PrP were labelled with a varying intensity of each of the anti-PrP sera. Secondary nodules of lymph nodes showed a diffuse extracellular pattern of staining within the light zone of the germinal centres, corresponding to the localization of FDCs (Jeffrey et al., 2000) . A more intense and dense immunostaining was seen throughout the germinal centres, including the dark zone and in the mantle. This pattern corresponded to intracytoplasmic staining of tingible body macrophages (Jeffrey et al., 2000) . To a R. Heggebø and others R. Heggebø and others variable extent, all the anti-PrP sera used in the present study gave weak or moderate staining of sinusoidal macrophages of mesenteric lymph nodes and cells of the paracortex, including the mesenteric lymph nodes in both the PrP ARR/ARR and PrP ARR/ARQ sheep. In the spleens of the clinically and subclinically affected Suffolk sheep, there was marked immunolabelling of tingible body macrophages in germinal centres and some nodules showed immunolabelling of FDCs in the light zone (Fig. 1) . Most of the anti-PrP sera gave virtually no labelling in the red pulp but in the marginal zone and in periarteriolar lymphocyte sheath of the white pulp : the cytoplasm of a variable number of mononuclear cells showed immunolabelling for PrP (Fig. 1) . These antibodies also produced virtually no staining in the red pulp of the PrP ARR/ARR and PrP ARR/ARQ sheep. However, in all sheep, including the PrP ARR/ARR and PrP ARR/ARQ sheep, the P4 antibody produced diffuse immunolabelling of the red pulp. In the PrP ARR/ARR and PrP ARR/ARQ sheep, discrete intense immunolabelling of a sub-population of mononuclear cells within the marginal zone was present. This pattern of marginal zone labelling was also present in the clinically and subclinically affected sheep. As with the other antibodies, the P4 antibody also produced immunolabelling of mononuclear cells in the periarteriolar lymphocyte sheaths and in germinal centres where there was prominent labelling of FDCs and tingible body macrophages. Weak staining of some connective tissue, including the capsule of secondary nodules, was also observed with the P4 and R486 antibodies.
Gut-associated lymphoid tissue. In the clinically and subclinically affected sheep, there were disease-associated accumulations of PrP in all nodules of Peyer's patches in the jejunum and ileum and in the lymphoid aggregates of the colon. Nodules in the tonsils of these animals also showed disease-associated accumulations of PrP. In the Peyer's patches and colonic aggregates of all sheep, including the PrP ARR/ARR and PrP ARR/ARQ sheep, immunostaining was detected in a small proportion of mononuclear cells of the dome, submucosal internodular areas and lamina propria with some of the antibodies used (Fig. 2) . The extent of this staining was most prominent with the R486 antibody. Other antibodies, such as R482, which is also a polyclonal antibody recognizing the same peptide sequence as R486, gave much less immunostaining of cells in the lamina propria. There were no disease-associated accumulations of PrP in the germinal centres of gut-associated lymphoid tissues of the PrP ARR/ARR or PrP ARR/ARQ sheep.
In the abomasum of some clinically affected sheep, several foci of inflammation were present in the mucosa, which closely resembled those induced by parasites in grazing sheep. These foci consisted of mainly lymphocytic and macrophage infiltrates, which sometimes formed nodules within the mucosa. Where nodules were present, immunohistochemical staining for PrP was also found (Fig. 2) . Similar accumulations of PrP were detected in acquired inflammatory foci containing lymphoid nodules in the duodenum and large intestine. EID R. Heggebø and others R. Heggebø and others 
Histoblots
In tissues from clinically and sub-clinically affected sheep, the histoblot findings were relatively consistent in all six sheep. Proteinase K-resistant PrP (PrP RES ) was detected in all of the organs examined, including ileal and jejunal Peyer's patches, lymphoid aggregates adjacent to the ileo-caeco-colic junction in colon, spleen, distal jejunal lymph node, superficial cervical lymph node and retropharyngeal lymph node.
The distribution of PrP RES was similar in the three lymph nodes examined. In the six PrP ARQ/ARQ sheep, staining was most prominent in the nodules in the lymph node cortex, although scattered foci of staining were present in the paracortex (Fig. 3) . Staining for PrP RES was also prominent in the nodules of the spleen. An area of weaker staining that was distinct from the nodular staining was detected in the spleen (Fig. 3) . This area corresponded to the region of the marginal zone.
In the gut-associated lymphoid tissues of the six PrP ARQ/ARQ sheep, staining for PrP RES was detected in lymphoid nodules. The pattern of staining for PrP RES in lymphoid nodules differed between the three sites examined in the alimentary tract. In the persisting lymphoid nodules of the ileal Peyer's patch, PrP RES was localized mainly to the light central zone and neck region of the nodules and the dark peripheral zone tended to show little or no staining (Fig. 4) . In the nodules of the jejunal Peyer's patch, staining for PrP RES tended to be distributed through the whole nodule, while the lymphoid nodules of the colon showed a distinct central belt of staining (Fig. 4) . At all three alimentary sites, nodules showed scattered foci of strong staining, presumably corresponding to tingible body macrophages, and there were some scattered foci of staining in the internodular areas (Fig. 4) . Staining for PrP RES was also detected in the capsule of lymphoid nodules at the three sites, which was not evident in the nodules of lymph nodes or the spleen (Figs 3 and 4) . In the tissues examined from the PrP ARR/ARR and PrP ARR/ARQ sheep, no PrP RES was detected.
Immunofluorescence
A double immunofluorescence technique was used on frozen tissue to examine the co-localization of PrP and CD21-positive cells in distal jejunal, superficial cervical and retropharyngeal lymph nodes, spleen and jejunal and ileal Peyer's patch. The distribution of staining for CD21 was similar in all eight sheep. In sheep, the main cellular reactivity of CD21 (complement receptor 2) is FDCs and a sub-population of B cells (Hein et al., 1998 ; Young et al., 1997) . The immunofluores-EIF R. Heggebø and others R. Heggebø and others cence technique used to detect PrP did not distinguish between PrP C and the disease-associated isoform of the protein. The level of staining for PrP that was detected in the two PrP ARR/ARR and PrP ARR/ARQ sheep was less in comparison with the level detected in the six PrP ARQ/ARQ sheep (Fig. 5) .
The pattern of double staining detected in the lymph nodes and spleen of the PrP ARQ/ARQ sheep was consistent in the six animals. Double staining for PrP and CD21 was prominent in the germinal centres of lymph node and splenic nodules. Scattered foci of double staining were also present in the paracortex of lymph nodes and periarteriolar lymphocyte sheaths of the spleen (Fig. 5) . In the jejunal and ileal Peyer's patches and the lymphoid aggregates of the colon of the PrP ARQ/ARQ sheep, double staining for PrP and CD21 was prominent in the light central zone of the nodules but only single staining for PrP or CD21 was present in the dome.
Discussion
The present study investigated the distribution of diseaseassociated accumulations of PrP in the lymphoid tissues of Suffolk sheep in the late sub-clinical and early clinical phase of natural scrapie and showed that disease-associated PrP was prominent throughout the lymphoid tissues examined in these sheep. The widespread presence of disease-associated PrP in the lymphoid tissues of both sub-clinically and clinically affected animals emphasizes the importance of identifying affected animals as early as possible in the course of the disease. A striking finding in the present study was the large accumulations of disease-associated PrP in the lymphoid follicles of the alimentary tract. Andre! oletti et al. (2000) commented that the progressive accumulation of diseaseassociated PrP in the gut-associated lymphoid tissues may lead to shedding of scrapie infectivity and contribute to transmission of the disease. However, the localization of diseaseassociated PrP in lymphoid nodules in the gut raises the question of the movement of the scrapie agent to the gut lumen and the more general issue of the transport of the scrapie agent throughout the lymphoid tissues of the body during the lymphoreticular involvement in the disease.
The present study showed a clear association between disease-associated PrP and lymphoid nodules. The pattern of distribution of disease-associated PrP in germinal centres and the co-localization of immunofluorescence staining for PrP and CD21 provide further documentation that FDCs are a significant site of accumulation of PrP in sheep. Previous studies have described the accumulation of PrP in lymphoid tissues of sheep (Andre! oletti et al., 2000 ; van Keulen et al., 1996 van Keulen et al., , 1999 and ultrastructural studies in scrapie-affected mice (Jeffrey et al., 2000) have reported the accumulation of diseaseassociated PrP in association with FDCs in secondary follicles but similar ultrastructural studies remain to be performed in sheep. Comprehensive studies in mice have shown that PrPexpressing FDCs are needed for disease (Brown et al., 1999) . However, the involvement of FDCs in the pathogenesis of TSEs is not without its complications. FDCs are a sessile cell population and are located in structures that are poorly innervated. Thus, other processes or cell populations must be involved in transporting the agent into the nodules and, presumably, away from the nodules. It should be noted that the origin of FDCs is still a matter of controversy. While it is widely accepted that FDCs are autochthonous cells originating from follicular mesenchymal cells (Rademakers, 1991) or reticular stromal cells (Dijkstra et al., 1984) , evidence has been EIG PrP in scrapie-affected Suffolk sheep PrP in scrapie-affected Suffolk sheep presented that FDCs derive from bone marrow-produced precursors that migrate to secondary lymphoid organs (Kapasi et al., 1998 ; Pasparakis et al., 2000) . However, the involvement of any mobile antigen-bearing cell population, including dendritic cells , in the transport of diseaseassociated PrP to lymphoid nodules remains to be documented.
Tingible body macrophages also showed a clear association with disease-associated PrP in lymphoid nodules of PrP ARQ/ARQ sheep. Tingible body macrophages are present throughout the lymphoid nodule and ingest apoptotic B cells and are thought to scavenge the ends of FDC processes (Ritchie et al., 2000 ; Szakal et al., 1988) . Jeffrey et al. (2000) found accumulations of PrP within lysosomes of tingible body macrophages and concluded that tingible body macrophages ingest excess or abnormal PrP from entire degenerate FDCs or their processes or by scavenging in the extracellular space. The other major cell population present in lymphoid nodules is the B cell. In the present study, a clear association of diseaseassociated PrP with B cells was not demonstrated. While B cells leave lymphoid nodules in large numbers and some studies have shown that the presence of B cells affects the course of disease (Klein et al., 1997) , the weight of evidence now suggests that the effect of B cells on the pathogenesis of TSE is through their influence on FDC maturation .
The present study used three methods and a broad range of anti-PrP antibodies to detect the presence of PrP in the PrP ARQ/ARQ sheep. While all three methods showed that the large majority of PrP was localized to lymphoid nodules in the tissues examined, the methods also showed consistently that PrP was to be detected away from nodular structures. Immunohistochemical staining for PrP was present in mononuclear cells in extra-nodular tissues, including the paracortex of lymph nodes and the dome of Peyer's patches. The histoblot examination also detected scattered foci of PrP RES away from the dense accumulations, which characterized lymphoid nodules. While some of this staining may represent nerve tissue, particularly in the gut, the involvement of leukocyte populations should be considered. The double immunofluorescence study found little or no double staining for PrP and CD21 outside the region of the germinal centres. In sheep, CD21 (complement receptor 2) is an integral membrane protein expressed on FDCs as well as on a sub-population of B cells (Hein et al., 1998) . In further research, it would be useful to use other markers to examine leukocyte populations, including macrophage and dendritic cell lineage cells in extra-nodular tissue, for the presence of PrP.
In the spleens of the clinically and sub-clinically affected PrP ARQ/ARQ sheep, immunolabelling for PrP was detected in the cells of the marginal zone and periarteriolar lymphocyte sheath. This immunolabelling was present with such different anti-PrP antibodies as the monoclonal antibodies P4 and R145 and the polyclonal antibody R486, suggesting that the staining was not an artefact. The involvement of the marginal zone in the lymphoreticular phase of scrapie was implicated further by histoblot examination of these animals, which showed a distinct presence of PrP RES away from the dense staining of nodules (Fig. 3) . The marginal zone lies between the white and red pulp of the spleen and is usually described as a layer surrounding the periarteriolar lymphocyte sheaths and B cell nodules. It is an area that contains distinctive lymphoid and non-lymphoid cell populations and is a site of the initial filtration and phagocytosis of antigens from blood and of leukocyte emigration (Kraal, 1992) . It is tempting to speculate that the disease-associated PrP in the marginal zone and possibly also in the periarteriolar lymphocyte sheath and other extra-nodular sites represents the on-going uptake, transport and elimination of disease-associated PrP by the mononuclear phagocyte system of the sheep. Studies in macrophagedepleted mice (Beringue et al., 2000) have shown that macrophages influence the course of disease and in vitro studies show that peritoneal macrophages are associated with scrapie infectivity, which decreases with time after exposure to the scrapie agent (Carp & Callahan, 1982) .
In natural scrapie, Suffolk sheep with PrP ARQ/ARQ genotype are susceptible to infection and sheep with PrP ARR/ARR or PrP ARR/ARQ genotypes are largely resistant to scrapie, although occasional rare cases have occurred in the PrP ARR/ARQ genotype (Hunter et al., 1997b ; O'Rourke et al., 1997 ; Westaway et al., 1994) . The two PrP ARR/ARR or PrP ARR/ARQ sheep in the present study did not show diseaseassociated accumulations of PrP in lymphoid nodules. However, tissues sections from these animals did show some immunohistochemical staining. Staining of paracortical and sinusoidal macrophages and some staining of dome cells were detected to a variable degree with all of the antibodies used in these control sheep. However, this staining was present to a greater extent in scrapie-affected sheep. The significance of this staining is presently uncertain. It may represent a non-specific binding feature of all antibodies to macrophages (which may perhaps be increased during infection) or may represent a specific up-regulation of PrP C bearing cells in disease, as suggested possibly by the higher levels of immunofluorescence staining for PrP detected in the PrP ARQ/ARQ sheep in the present study. PrP RES was not detected in the PrP ARR/ARR or PrP ARR/ARQ sheep, which would argue for the immunohistochemical detection of PrP C in these sheep.
In conclusion, this study shows that the presence of diseaseassociated PrP is similar in late sub-clinical and clinically affected PrP ARQ/ARQ Suffolk sheep. The dominant localization of PrP was in the lymphoid nodules but the consistent presence of PrP in extra-nodular sites, such as the dome of Peyer's patches, paracortex of lymph nodes and the marginal zone of the spleen, suggests the involvement of the mononuclear phagocyte system in the lymphoreticular phase of scrapie in sheep. The participation of extra-nodular cell populations in the uptake, transport and elimination of disease-associated PrP may provide the ' missing link ' that allows the dense R. Heggebø and others R. Heggebø and others accumulations of disease-associated PrP in lymphoid nodules to facilitate neuroinvasion and to promote shedding of the scrapie agent to the environment.
